Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$3.14 - $3.9 $6,594 - $8,190
-2,100 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$3.8 - $4.56 $16,195 - $19,434
-4,262 Reduced 66.99%
2,100 $8,000
Q1 2021

May 17, 2021

BUY
$4.33 - $6.63 $1,394 - $2,134
322 Added 5.33%
6,362 $29,000
Q3 2020

Nov 13, 2020

SELL
$15.08 - $27.04 $18,985 - $34,043
-1,259 Reduced 17.25%
6,040 $100,000
Q2 2020

Aug 14, 2020

BUY
$14.57 - $23.96 $12,734 - $20,941
874 Added 13.6%
7,299 $170,000
Q1 2020

May 14, 2020

SELL
$10.27 - $21.23 $4,190 - $8,661
-408 Reduced 5.97%
6,425 $95,000
Q4 2019

Feb 13, 2020

BUY
$8.36 - $23.81 $677 - $1,928
81 Added 1.2%
6,833 $140,000
Q3 2019

Nov 13, 2019

BUY
$9.83 - $14.82 $20,643 - $31,122
2,100 Added 45.14%
6,752 $66,000
Q2 2019

Aug 14, 2019

BUY
$12.9 - $20.8 $7,443 - $12,001
577 Added 14.16%
4,652 $63,000
Q1 2019

May 15, 2019

BUY
$17.7 - $24.93 $4,035 - $5,684
228 Added 5.93%
4,075 $80,000
Q4 2018

Feb 15, 2019

BUY
$19.05 - $36.45 $10,629 - $20,339
558 Added 16.97%
3,847 $87,000
Q3 2018

Nov 20, 2018

BUY
$34.41 - $44.23 $21,196 - $27,245
616 Added 23.05%
3,289 $122,000
Q2 2018

Aug 10, 2018

SELL
$39.21 - $50.29 $12,194 - $15,640
-311 Reduced 10.42%
2,673 $105,000
Q1 2018

May 17, 2018

SELL
$41.7 - $64.16 $34,986 - $53,830
-839 Reduced 21.95%
2,984 $146,000
Q4 2017

Feb 13, 2018

BUY
$28.58 - $49.91 $109,261 - $190,805
3,823
3,823 $171,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $713M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.